Institutional investors purchased a net $1.4 million shares of GIVN during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 23.73% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
| Mutual fund holders | 12.98% |
| Individual stakeholders | 11.51% |
| Other institutional | 10.75% |